| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/13/2000 | WO2000020585A1 Mammalian timeless and methods of use thereof |
| 04/13/2000 | WO2000020584A2 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6 |
| 04/13/2000 | WO2000020583A1 Ribonucleoprotein homolog zrnp1, having also homology to the gnrh receptor |
| 04/13/2000 | WO2000020582A2 Gene replacement therapy for muscular dystrophy |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020580A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/13/2000 | WO2000020579A1 Spliced form of erbb-2/neu oncogene |
| 04/13/2000 | WO2000020578A1 A method of modulating cell survival and reagents useful for same |
| 04/13/2000 | WO2000020576A2 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
| 04/13/2000 | WO2000020575A1 Pollinosis-associated gene |
| 04/13/2000 | WO2000020574A2 Fusions of scaffold proteins with random peptide libraries |
| 04/13/2000 | WO2000020573A2 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 04/13/2000 | WO2000020572A2 Tissue binding peptides, identification, production and utilization thereof |
| 04/13/2000 | WO2000020571A2 Maize promoters |
| 04/13/2000 | WO2000020570A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
| 04/13/2000 | WO2000020566A2 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
| 04/13/2000 | WO2000020560A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 04/13/2000 | WO2000020558A1 METHOD FOR PREPARING HIGH PERFORMANCE RecA-LIKE RECOMBINASE/SINGLE-STRANDED NUCLEIC ACID PROBE COMPLEX AND UTILIZATION THEREOF |
| 04/13/2000 | WO2000020557A2 Gemini virus vectors for gene expression in plants |
| 04/13/2000 | WO2000020555A2 Transformation system in the field of filamentous fungal hosts: in chrysosporium |
| 04/13/2000 | WO2000020460A1 Methods for producing human tumor antigen specific antibodies |
| 04/13/2000 | WO2000020459A1 Crystals of the alpha 1 beta 1 integrin i-domain and their use |
| 04/13/2000 | WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | WO2000020456A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/13/2000 | WO2000020455A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/13/2000 | WO2000020452A2 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 04/13/2000 | WO2000020450A2 Calcium channel alpha-2/delta gene |
| 04/13/2000 | WO2000020449A2 MODIFIED TGF-β SUPERFAMILY PROTEINS |
| 04/13/2000 | WO2000020448A2 Nlk1 -interacting proteins |
| 04/13/2000 | WO2000020447A2 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
| 04/13/2000 | WO2000020446A2 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 04/13/2000 | WO2000020444A1 Novel peptides |
| 04/13/2000 | WO2000020443A1 Novel peptides |
| 04/13/2000 | WO2000020442A1 Tumor-specific antigen peptides |
| 04/13/2000 | WO2000020438A1 G protein-coupled receptor resembling the thrombin receptor |
| 04/13/2000 | WO2000020435A1 ANTISENSE MODULATION OF EXPRESSION OF TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED FACTORS (TRAFs) |
| 04/13/2000 | WO2000020434A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | WO2000020433A1 Cytotoxic agents for the selective killing of lymphoma and leukemia cells and methods of use thereof |
| 04/13/2000 | WO2000020432A1 Antisense modulation of bcl-x expression |
| 04/13/2000 | WO2000020429A1 3',5'-cyclic phosphate compounds and methods thereof |
| 04/13/2000 | WO2000020114A1 Adsorbent medium and its use in purifying dna |
| 04/13/2000 | WO2000020040A1 Controlling gene expression in living cells |
| 04/13/2000 | WO2000020039A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | WO2000020038A1 Method of treating prostate cancer with an adenovirus vector |
| 04/13/2000 | WO2000020037A1 A novel component in the hedgehog signalling pathway |
| 04/13/2000 | WO2000020029A1 Genes differentially expressed in cancer cells to design cancer vaccines |
| 04/13/2000 | WO2000020027A2 Methods for therapeutic vaccination |
| 04/13/2000 | WO2000020025A2 Akt compositions for enhancing survival of cells |
| 04/13/2000 | WO2000020020A2 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 04/13/2000 | WO2000020018A1 Kappa-a conopeptides and uses therefor |
| 04/13/2000 | WO2000020011A1 Isolated dna encoding human h3 histamine receptor |
| 04/13/2000 | WO2000019988A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 04/13/2000 | WO2000019883A2 Compositions and methods of disease diagnosis and therapy |
| 04/13/2000 | WO2000019832A1 Vegetable oil having elevated stearic acid content |
| 04/13/2000 | WO2000019806A1 High temperature-tolerant plants |
| 04/13/2000 | WO2000003028A3 Method for optimizing the production of adenovirus vectors |
| 04/13/2000 | WO2000003015A3 Human transport protein homologs |
| 04/13/2000 | WO2000003010A3 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 04/13/2000 | WO2000001831A3 Proteases fused with variants of streptomyces subtilisin inhibitor |
| 04/13/2000 | WO2000001813A3 Peptide inhibitors of androgen-independent activation of androgen receptor |
| 04/13/2000 | WO2000000620A3 Dna encoding methymycin and pikromycin |
| 04/13/2000 | WO2000000608A3 Immune system molecules |
| 04/13/2000 | WO2000000603A3 Modularly constructed rna molecules having two sequence region types |
| 04/13/2000 | WO1999067428A3 Method for detection of drug-selected mutations in the hiv protease gene |
| 04/13/2000 | WO1999065924A3 Preparation and use of superior vaccines |
| 04/13/2000 | WO1999064576A3 Human genes differentially expressed in colon cancer |
| 04/13/2000 | WO1999063094A3 Nucleotide and protein sequences of gpr1 and methods based thereon |
| 04/13/2000 | WO1999063078A3 Retinal calcium channel (alpha)1f-subunit gene |
| 04/13/2000 | WO1999061616A3 DNA CODING FOR A Mg?2+/H+ OR Zn2+/H+¿ EXCHANGER AND TRANSGENIC PLANTS EXPRESSING SAME |
| 04/13/2000 | WO1999061598A3 Lentiviral vector compositions and methods of use |
| 04/13/2000 | WO1999060110A3 Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy |
| 04/13/2000 | WO1999059562A3 Method of treating or preventing abnormal cardiac cell growth by inhibiting the 12-lipoxygenase pathway |
| 04/13/2000 | WO1999055888A3 Carotenoid biosynthesis enzymes |
| 04/13/2000 | WO1999055887A3 Carotenoid biosynthesis enzymes |
| 04/13/2000 | WO1999055875A3 VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS) |
| 04/13/2000 | WO1999055720A9 Targeted gene delivery to cells by filamentous bacteriophage |
| 04/13/2000 | WO1999055345A9 Combination viral-based and gene-based therapy of tumors |
| 04/13/2000 | WO1999051755A3 Ribozyme-mediated control of gene expression |
| 04/13/2000 | WO1999051265A9 Nucleic acid encoding hyaluronan synthase and methods of use |
| 04/13/2000 | WO1999035241A9 Transgenic rabbit that expresses a functional human lipoprotein (a) |
| 04/13/2000 | DE19852800C1 Production of antibodies to a polypeptide encoded by a known DNA sequence comprises binding of antibodies produced by DNA vaccination to immobilized recombinantly expressed polypeptide |
| 04/13/2000 | DE19846838A1 Recombinant Drosophila deoxynucleotide kinase useful for preparing nucleoside monophosphates by phosphorylating nucleosides |
| 04/13/2000 | DE19846493A1 DNA sequence coding for products involved in the biosynthesis of polyketide or heteropolyketide compounds, especially epothilone |
| 04/13/2000 | DE19845420A1 Interzelluläre Ausbreitung rekombinanter DNA Intercellular propagation of recombinant DNA |
| 04/13/2000 | CA2816178A1 Vegetable oil having elevated stearic acid content |
| 04/13/2000 | CA2763753A1 Vegetable oil having elevated stearic acid content |
| 04/13/2000 | CA2657302A1 Modified tgf-.beta. superfamily proteins |
| 04/13/2000 | CA2653985A1 Cytochrome p450 monooxygenase and nadph cytochrome p450 oxidoreductase genes and proteins related to the omega hydroxylase complex of candida tropicalis and methods relating thereto |
| 04/13/2000 | CA2354863A1 Prevention of adhesions |
| 04/13/2000 | CA2354544A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele |
| 04/13/2000 | CA2347120A1 Nlk1 -interacting proteins |
| 04/13/2000 | CA2346765A1 Compositions and methods of disease diagnosis and therapy |
| 04/13/2000 | CA2346496A1 Novel th2-specific molecules and uses thereof |
| 04/13/2000 | CA2346452A1 Methods and adjuvants for stimulating mucosal immunity |
| 04/13/2000 | CA2346327A1 Hypersensitive response elicitor from xanthomonas campestris |
| 04/13/2000 | CA2346217A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | CA2346134A1 G protein-coupled receptor resembling the thrombin receptor |
| 04/13/2000 | CA2346070A1 Bax-mediated apoptosis modulating reagents and methods |
| 04/13/2000 | CA2345881A1 Bone marrow-derived serum proteins |